Ameriprise’s Pliant Therapeutics PLRX Stock Holding History

Ameriprise’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$62.8K	Hold	55,129	–	–	﹤0.01%	4049
2026 Q1	$69.5K	Buy	+55,129	New	+$69.6K	﹤0.01%	3989
2024 Q2	–	Sell	-371,126	Closed	-$5.53M	–	3922
2024 Q1	$5.53M	Buy	371,126 +1,325	+0.4%	+$21.9K	﹤0.01%	2298
2023 Q4	$6.7M	Sell	369,801 -2,326	-0.6%	-$35.4K	﹤0.01%	2123
2023 Q3	$6.45M	Buy	+372,127	New	+$6.45M	﹤0.01%	2087

Other funds holding PLRX

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Ameriprise's PLRX Position: Q2 2026 in Review

Ameriprise held its Pliant Therapeutics (PLRX) position steady in Q2 2026 at 55,129 shares worth $62.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4049.

Ameriprise first reported a position in PLRX in Q3 2023 and has held it in 5 quarters since. The position peaked at $6.7M in Q4 2023. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

Ameriprise held 55,129 shares of Pliant Therapeutics worth $62.8K as of Q2 2026.
Ameriprise left its Pliant Therapeutics share count unchanged in Q2 2026.
Pliant Therapeutics made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #4049 holding.
Ameriprise first reported a position in Pliant Therapeutics in Q3 2023 and has held it in 5 quarters since.
Ameriprise's Pliant Therapeutics position peaked at $6.7M in Q4 2023.
86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.